<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03079661</url>
  </required_header>
  <id_info>
    <org_study_id>RNI2016-42</org_study_id>
    <nct_id>NCT03079661</nct_id>
  </id_info>
  <brief_title>Impact of Air Quality on Exacerbations of COPD in the Somme</brief_title>
  <acronym>PolluBPCO</acronym>
  <official_title>Impact of Air Quality on Exacerbations of COPD in the Somme</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      All COPD patients with a diagnosis of acute exacerbation in emergency room in University
      Hospital of Amiens-Picardie between 01/01/2017 and 31/12/2017. The investigator will collect
      for each patient the home address and the work address. The duration of 1 year was chosen to
      take into account seasonal variations. In parallel, a daily report of the rate of ozone,
      particles (PM2.5 and PM10), dioxide nitrogen but also odours and pollens will be done by ATMO
      Picardie.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    investigator choice
  </why_stopped>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Actual">January 14, 2019</completion_date>
  <primary_completion_date type="Actual">January 14, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>exacerbation rate : variable to be explicated with explicative variable : ozone, particles, dioxide nitrogen, but also pollens corresponding to each patient home address for period of exacerbation</measure>
    <time_frame>1 day</time_frame>
    <description>exacerbation rate : variable to be explicated with explicative variable : ozone, particles, dioxide nitrogen, but also pollens corresponding to each patient home address for period of exacerbation</description>
  </primary_outcome>
  <enrollment type="Actual">179</enrollment>
  <condition>Acute Exacerbation Copd</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The primary endpoint is the number of exacerbations of COPD corresponding to the variable
        of interest to be explained. The other variables are the explanatory variables (air quality
        data PM2.5, PM10, NO2, O3 as well as pollen data, seasonal variations, influenza epidemic
        and olfactory nuisance). The final diagnosis will also be collected.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All COPD patients with a diagnosis of acute exacerbation of COPD in the emergency
             room. The definition of COPD and acute exacerbation are the official definition of the
             Société de Pneumologie en Langue Française.

        Exclusion Criteria:

          -  no exclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU Amiens Picardie</name>
      <address>
        <city>Amiens</city>
        <state>Picardie</state>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>March 9, 2017</study_first_submitted>
  <study_first_submitted_qc>March 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 14, 2017</study_first_posted>
  <last_update_submitted>July 13, 2020</last_update_submitted>
  <last_update_submitted_qc>July 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pollution</keyword>
  <keyword>ozone</keyword>
  <keyword>Copd</keyword>
  <keyword>particles</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

